SA Interview: Biotech Investing With E. Roudasev
seekingalpha.com
finance
2022-10-15 11:30:00

Feature interview E. Roudasev is a senior business manager for a major financial institution. Her areas of interest are biotech, environmental tech and credit risks. We discussed the contrarian opportunity after seemingly negative drug trial results, what to focus on when reviewing drug trial results, and the importance of reviewing the balance sheet and burn rate. Seeking Alpha: Walk us through your investment decision making process. What area of the market do you focus on and what strategies do you employ? E.
